These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 19817406)

  • 1. Ligand binding and hydration in protein misfolding: insights from studies of prion and p53 tumor suppressor proteins.
    Silva JL; Vieira TC; Gomes MP; Bom AP; Lima LM; Freitas MS; Ishimaru D; Cordeiro Y; Foguel D
    Acc Chem Res; 2010 Feb; 43(2):271-9. PubMed ID: 19817406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein folding and aggregation: two sides of the same coin in the condensation of proteins revealed by pressure studies.
    Silva JL; Cordeiro Y; Foguel D
    Biochim Biophys Acta; 2006 Mar; 1764(3):443-51. PubMed ID: 16480935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pressure-temperature folding landscape in proteins involved in neurodegenerative diseases and cancer.
    Cordeiro Y; Foguel D; Silva JL
    Biophys Chem; 2013 Dec; 183():9-18. PubMed ID: 23849959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic prions and other human neurodegenerative proteinopathies.
    Le NT; Narkiewicz J; Aulić S; Salzano G; Tran HT; Scaini D; Moda F; Giachin G; Legname G
    Virus Res; 2015 Sep; 207():25-37. PubMed ID: 25449570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein Misfolding Cyclic Amplification of Infectious Prions.
    Moda F
    Prog Mol Biol Transl Sci; 2017; 150():361-374. PubMed ID: 28838669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The "Jekyll and Hyde" Actions of Nucleic Acids on the Prion-like Aggregation of Proteins.
    Silva JL; Cordeiro Y
    J Biol Chem; 2016 Jul; 291(30):15482-90. PubMed ID: 27288413
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Eraña H; Fernández-Borges N; Elezgarai SR; Harrathi C; Charco JM; Chianini F; Dagleish MP; Ortega G; Millet Ó; Castilla J
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prions and the potential transmissibility of protein misfolding diseases.
    Kraus A; Groveman BR; Caughey B
    Annu Rev Microbiol; 2013; 67():543-64. PubMed ID: 23808331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental approaches to the interaction of the prion protein with nucleic acids and glycosaminoglycans: Modulators of the pathogenic conversion.
    Silva JL; Vieira TC; Gomes MP; Rangel LP; Scapin SM; Cordeiro Y
    Methods; 2011 Mar; 53(3):306-17. PubMed ID: 21145399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of pH on the human prion protein: insights into the early steps of misfolding.
    van der Kamp MW; Daggett V
    Biophys J; 2010 Oct; 99(7):2289-98. PubMed ID: 20923664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expansion of the octarepeat domain alters the misfolding pathway but not the folding pathway of the prion protein.
    Leliveld SR; Stitz L; Korth C
    Biochemistry; 2008 Jun; 47(23):6267-78. PubMed ID: 18473442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural insight into the antiprion compound inhibition mechanism of native prion folding over misfolding.
    Choi J; Govindaraj RG; Hyeon JW; Lee K; Ma S; Kim SY; Lee J; No KT
    Chem Biol Drug Des; 2017 Jun; 89(6):907-917. PubMed ID: 27933736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The amino-terminal PrP domain is crucial to modulate prion misfolding and aggregation.
    Cordeiro Y; Kraineva J; Gomes MP; Lopes MH; Martins VR; Lima LM; Foguel D; Winter R; Silva JL
    Biophys J; 2005 Oct; 89(4):2667-76. PubMed ID: 16040743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of misfolding of the human prion protein revealed by a pathological mutation.
    Sanz-Hernández M; Barritt JD; Sobek J; Hornemann S; Aguzzi A; De Simone A
    Proc Natl Acad Sci U S A; 2021 Mar; 118(12):. PubMed ID: 33731477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cell biology of prion-like spread of protein aggregates: mechanisms and implication in neurodegeneration.
    Costanzo M; Zurzolo C
    Biochem J; 2013 May; 452(1):1-17. PubMed ID: 23614720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prion disease: a deadly disease for protein misfolding.
    Chakraborty C; Nandi S; Jana S
    Curr Pharm Biotechnol; 2005 Apr; 6(2):167-77. PubMed ID: 15853695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloids, prions and the inherent infectious nature of misfolded protein aggregates.
    Soto C; Estrada L; Castilla J
    Trends Biochem Sci; 2006 Mar; 31(3):150-5. PubMed ID: 16473510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.
    Ugalde CL; Finkelstein DI; Lawson VA; Hill AF
    J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prion protein misfolding and disease.
    Moore RA; Taubner LM; Priola SA
    Curr Opin Struct Biol; 2009 Feb; 19(1):14-22. PubMed ID: 19157856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydration and packing effects on prion folding and beta-sheet conversion. High pressure spectroscopy and pressure perturbation calorimetry studies.
    Cordeiro Y; Kraineva J; Ravindra R; Lima LM; Gomes MP; Foguel D; Winter R; Silva JL
    J Biol Chem; 2004 Jul; 279(31):32354-9. PubMed ID: 15173173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.